Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Apr
17
2024
Weight Loss, Miracle Medications & the Workplace Robinson & Cole LLP
Nov
5
2020
ShopRite Settles with NJ AG for Data Breach Robinson & Cole LLP
Oct
21
2021
EPA Releases PFAS Strategic Roadmap - October 21, 2021 Robinson & Cole LLP
Oct
25
2022
Advisory Opinion 22-19: OIG Warns That Proposed Drug Cost Subsidization Arrangement May Warrant Sanctions Robinson & Cole LLP
Jan
28
2020
DOJ Reaches Settlement with Patient Assistance Foundation Resolving Allegations of FCA Violations Robinson & Cole LLP
May
8
2020
Connecticut Governor Ned Lamont Issues Executive Order Allowing Pharmacists to Order COVID-19 Tests Robinson & Cole LLP
May
25
2022
Connecticut Makes Significant Changes to its Collaborative Drug Therapy Laws Robinson & Cole LLP
Jan
7
2023
CBP Officers at the San Ysidro Port of Entry Seize Over $2 Million Worth of Cocaine U.S. Customs and Border Protection
Oct
24
2021
CBP Issues Withhold Release Order on Tomatoes Produced by Farm in Mexico U.S. Customs and Border Protection
Nov
7
2022
CBP Officers Seize $18.6 Million in Methamphetamine at Laredo Port of Entry U.S. Customs and Border Protection
Sep
24
2022
413 Pounds of Concealed Marijuana Intercepted by Cincinnati CBP U.S. Customs and Border Protection
Mar
21
2024
A Psychedelic Use Case for AI Nelson Mullins
Feb
13
2023
Old North State Report – Feb. 13, 2023 Nelson Mullins
Mar
23
2023
FDA Revises Recommendations Regarding Electronic Systems, Records, and Signatures in Clinical Investigations Nelson Mullins
May
30
2023
FDA Studies Foreshadow Potential Changes to Direct-to-Consumer Prescription Drug Advertising Nelson Mullins
May
7
2021
Court Issues a Rare, Severe Discovery Sanction: The Path that Led to Default Judgment Nelson Mullins
May
25
2023
FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities Nelson Mullins
Jun
16
2023
NEWMOA Releases First-of-its-kind PFAS Regional Draft Model Legislation for Public Comment Nelson Mullins
Mar
19
2022
Gold Dome Report – Legislative Day 31 Nelson Mullins
Jun
20
2022
Transgender Youth and Access to Healthcare Nelson Mullins
Jan
31
2023
Old North State Report – Jan. 30, 2023 Nelson Mullins
Jan
18
2023
First Major Overhaul of Cosmetics Regulation Since FDR Administration Nelson Mullins
Jan
25
2023
FDA Finalizes Cannabis Guidance Focusing on Clinical Research and Quality Considerations Nelson Mullins
Jan
29
2024
Gold Dome Report – Legislative Day 10 (2024) Nelson Mullins
Jul
12
2021
Biden Executive Order Addresses Healthcare Industry Competition, Targets Pharmaceuticals, Pricing, and Hospital Mergers Nelson Mullins
Apr
6
2023
FDA Announces First-Ever AI/ML Medical Device Draft Guidance Nelson Mullins
Jun
30
2023
Old North State Report – June 30, 2023 Nelson Mullins
Apr
17
2023
FDA Publishes Implementation Policy Regarding Cybersecurity Requirements for Medical Device Premarket Submissions Nelson Mullins
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins